 | • レポートコード：QYR9ST04116 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、胆管がん（胆管細胞がん）治療の世界市場について調査・分析し、胆管がん（胆管細胞がん）治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物治療、放射線治療、手術）、用途別（肝内胆管がん、肝外胆管がん）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の胆管がん（胆管細胞がん）治療市場動向 ・主要企業別マーケットシェア ・胆管がん（胆管細胞がん）治療の種類別市場規模2014-2019 （薬物治療、放射線治療、手術） ・胆管がん（胆管細胞がん）治療の用途別市場規模2014-2019 （肝内胆管がん、肝外胆管がん） ・胆管がん（胆管細胞がん）治療の北米市場：主要企業・種類別/用途別市場規模 ・胆管がん（胆管細胞がん）治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・胆管がん（胆管細胞がん）治療の中国市場：主要企業・種類別/用途別市場規模 ・胆管がん（胆管細胞がん）治療の日本国内市場：主要企業・種類別/用途別市場規模 ・胆管がん（胆管細胞がん）治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・胆管がん（胆管細胞がん）治療のインド市場：主要企業・種類別/用途別市場規模 ・胆管がん（胆管細胞がん）治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Accord Healthcare、Bristol-Myers Squibb Company、Celgene Corporation、Delcath Systems、Eli Lilly and Company、F. Hoffman-La Roche、Fresenius Kabi、Johnson & Johnson Services、Kyowa Hakko Kirin、Mylan、Novartis、Pfizer、Sanofi、Teva Pharmaceuticals Industries） ・胆管がん（胆管細胞がん）治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Bile duct is a network of tube that connects the liver to the gall bladder. Bile duct carries a fluid called bile which is synthesize in the liver and stored in the gall bladder. The primary function of bile is breakdown of fats during digestion. Bile duct cancer is commonly known as cholangiocarcinoma. The particular cause of bile duct cancer is unknown but few factors that are responsible for developing bile duct cancer are long-term inflammation in the liver, biliary stones, abnormalities in bile duct such as cysts, infection with liver flukes parasite that causes infection in bile duct leading to cancer, and exposure to harmful chemicals and toxins. Major symptoms associated with bile duct cancer includes jaundice, weight loss, loss of appetite, discoloration of urine and stool, abdominal pain, itching, and fever. The industrialization in developing counters such as India, China, and other ASEAN countries led to increased exposure to harmful chemicals that are affecting the workers and leading to growth in the incidence of bile duct cancer among the industrial workforce, which is expected to drive market growth positively over the forecast period. Moreover, growing number of drugs has been awarded Orphan drug designation, which also expected to increase the market access and product demand across the globe and leading to lucrative market opportunities for the players in the market.
The market for bile duct cancer treatment is growing at healthy CAGR across the globe owing to rising incidence and prevalence of bile duct cancer across the globe. Moreover, the significant market growth has been observed in developing regions of Asia-pacific and Middle Eastern regions owing to common parasitic infection of the bile duct in these regions. For instance, according to The Cholangiocarcinoma Foundation, About 6,000 people in the United States develop bile duct cancer each year and Bile duct cancer is much more common in Asia and the Middle East, mostly because of a common parasitic infection of the bile duct.
In 2018, the global Bile Duct Cancer (Cholangiocarcinoma) Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Bile Duct Cancer (Cholangiocarcinoma) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bile Duct Cancer (Cholangiocarcinoma) Treatment development in United States, Europe and China.
The key players covered in this study
Accord Healthcare
Bristol-Myers Squibb Company
Celgene Corporation
Delcath Systems
Eli Lilly and Company
F. Hoffman-La Roche
Fresenius Kabi
Johnson & Johnson Services
Kyowa Hakko Kirin
Mylan
Novartis
Pfizer
Sanofi
Teva Pharmaceuticals Industries
Market segment by Type, the product can be split into
Drug Therapy
Radiation Therapy
Surgery
Market segment by Application, split into
Intrahepatic Bile Duct Cancer
Extrahepatic Bile Duct Cancer
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Bile Duct Cancer (Cholangiocarcinoma) Treatment status, future forecast, growth opportunity, key market and key players.
To present the Bile Duct Cancer (Cholangiocarcinoma) Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Bile Duct Cancer (Cholangiocarcinoma) Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Drug Therapy
1.4.3 Radiation Therapy
1.4.4 Surgery
1.5 Market by Application
1.5.1 Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share by Application (2014-2025)
1.5.2 Intrahepatic Bile Duct Cancer
1.5.3 Extrahepatic Bile Duct Cancer
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size
2.2 Bile Duct Cancer (Cholangiocarcinoma) Treatment Growth Trends by Regions
2.2.1 Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Regions (2014-2025)
2.2.2 Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Manufacturers
3.1.1 Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Bile Duct Cancer (Cholangiocarcinoma) Treatment Key Players Head office and Area Served
3.3 Key Players Bile Duct Cancer (Cholangiocarcinoma) Treatment Product/Solution/Service
3.4 Date of Enter into Bile Duct Cancer (Cholangiocarcinoma) Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Type (2014-2019)
4.2 Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size (2014-2019)
5.2 Bile Duct Cancer (Cholangiocarcinoma) Treatment Key Players in United States
5.3 United States Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Type
5.4 United States Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Application
6 Europe
6.1 Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size (2014-2019)
6.2 Bile Duct Cancer (Cholangiocarcinoma) Treatment Key Players in Europe
6.3 Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Type
6.4 Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Application
7 China
7.1 China Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size (2014-2019)
7.2 Bile Duct Cancer (Cholangiocarcinoma) Treatment Key Players in China
7.3 China Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Type
7.4 China Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Application
8 Japan
8.1 Japan Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size (2014-2019)
8.2 Bile Duct Cancer (Cholangiocarcinoma) Treatment Key Players in Japan
8.3 Japan Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Type
8.4 Japan Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size (2014-2019)
9.2 Bile Duct Cancer (Cholangiocarcinoma) Treatment Key Players in Southeast Asia
9.3 Southeast Asia Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Type
9.4 Southeast Asia Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Application
10 India
10.1 India Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size (2014-2019)
10.2 Bile Duct Cancer (Cholangiocarcinoma) Treatment Key Players in India
10.3 India Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Type
10.4 India Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size (2014-2019)
11.2 Bile Duct Cancer (Cholangiocarcinoma) Treatment Key Players in Central & South America
11.3 Central & South America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Type
11.4 Central & South America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Application
12 International Players Profiles
12.1 Accord Healthcare
12.1.1 Accord Healthcare Company Details
12.1.2 Company Description and Business Overview
12.1.3 Bile Duct Cancer (Cholangiocarcinoma) Treatment Introduction
12.1.4 Accord Healthcare Revenue in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)
12.1.5 Accord Healthcare Recent Development
12.2 Bristol-Myers Squibb Company
12.2.1 Bristol-Myers Squibb Company Company Details
12.2.2 Company Description and Business Overview
12.2.3 Bile Duct Cancer (Cholangiocarcinoma) Treatment Introduction
12.2.4 Bristol-Myers Squibb Company Revenue in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)
12.2.5 Bristol-Myers Squibb Company Recent Development
12.3 Celgene Corporation
12.3.1 Celgene Corporation Company Details
12.3.2 Company Description and Business Overview
12.3.3 Bile Duct Cancer (Cholangiocarcinoma) Treatment Introduction
12.3.4 Celgene Corporation Revenue in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)
12.3.5 Celgene Corporation Recent Development
12.4 Delcath Systems
12.4.1 Delcath Systems Company Details
12.4.2 Company Description and Business Overview
12.4.3 Bile Duct Cancer (Cholangiocarcinoma) Treatment Introduction
12.4.4 Delcath Systems Revenue in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)
12.4.5 Delcath Systems Recent Development
12.5 Eli Lilly and Company
12.5.1 Eli Lilly and Company Company Details
12.5.2 Company Description and Business Overview
12.5.3 Bile Duct Cancer (Cholangiocarcinoma) Treatment Introduction
12.5.4 Eli Lilly and Company Revenue in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)
12.5.5 Eli Lilly and Company Recent Development
12.6 F. Hoffman-La Roche
12.6.1 F. Hoffman-La Roche Company Details
12.6.2 Company Description and Business Overview
12.6.3 Bile Duct Cancer (Cholangiocarcinoma) Treatment Introduction
12.6.4 F. Hoffman-La Roche Revenue in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)
12.6.5 F. Hoffman-La Roche Recent Development
12.7 Fresenius Kabi
12.7.1 Fresenius Kabi Company Details
12.7.2 Company Description and Business Overview
12.7.3 Bile Duct Cancer (Cholangiocarcinoma) Treatment Introduction
12.7.4 Fresenius Kabi Revenue in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)
12.7.5 Fresenius Kabi Recent Development
12.8 Johnson & Johnson Services
12.8.1 Johnson & Johnson Services Company Details
12.8.2 Company Description and Business Overview
12.8.3 Bile Duct Cancer (Cholangiocarcinoma) Treatment Introduction
12.8.4 Johnson & Johnson Services Revenue in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)
12.8.5 Johnson & Johnson Services Recent Development
12.9 Kyowa Hakko Kirin
12.9.1 Kyowa Hakko Kirin Company Details
12.9.2 Company Description and Business Overview
12.9.3 Bile Duct Cancer (Cholangiocarcinoma) Treatment Introduction
12.9.4 Kyowa Hakko Kirin Revenue in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)
12.9.5 Kyowa Hakko Kirin Recent Development
12.10 Mylan
12.10.1 Mylan Company Details
12.10.2 Company Description and Business Overview
12.10.3 Bile Duct Cancer (Cholangiocarcinoma) Treatment Introduction
12.10.4 Mylan Revenue in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)
12.10.5 Mylan Recent Development
12.11 Novartis
12.12 Pfizer
12.13 Sanofi
12.14 Teva Pharmaceuticals Industries
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Bile Duct Cancer (Cholangiocarcinoma) Treatment Key Market Segments
Table Key Players Bile Duct Cancer (Cholangiocarcinoma) Treatment Covered
Table Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Market Share by Type 2014-2025
Figure Drug Therapy Figures
Table Key Players of Drug Therapy
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figure Surgery Figures
Table Key Players of Surgery
Table Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Intrahepatic Bile Duct Cancer Case Studies
Figure Extrahepatic Bile Duct Cancer Case Studies
Figure Bile Duct Cancer (Cholangiocarcinoma) Treatment Report Years Considered
Table Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size 2014-2025 (Million US$)
Figure Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share by Regions 2014-2019
Figure Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share by Regions 2014-2019
Figure Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share by Manufacturers (2014-2019)
Figure Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share by Manufacturers in 2018
Table Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Bile Duct Cancer (Cholangiocarcinoma) Treatment Product/Solution/Service
Table Date of Enter into Bile Duct Cancer (Cholangiocarcinoma) Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Share by Type (2014-2019)
Figure Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Market Share by Type (2014-2019)
Table Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Share by Application (2014-2019)
Figure Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Market Share by Application (2014-2019)
Figure Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Revenue Market Share by Application in 2018
Figure United States Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Bile Duct Cancer (Cholangiocarcinoma) Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share (2018-2019)
Table United States Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share by Type (2014-2019)
Table United States Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share by Application (2014-2019)
Figure Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Bile Duct Cancer (Cholangiocarcinoma) Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share (2018-2019)
Table Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share by Type (2014-2019)
Table Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share by Application (2014-2019)
Figure China Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Bile Duct Cancer (Cholangiocarcinoma) Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share (2018-2019)
Table China Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Type (2014-20189) (Million US$)
Table China Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share by Type (2014-2019)
Table China Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Application (2014-2019) (Million US$)
Table China Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share by Application (2014-2019)
Figure Japan Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Bile Duct Cancer (Cholangiocarcinoma) Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share (2018-2019)
Table Japan Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share by Type (2014-2019)
Table Japan Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Bile Duct Cancer (Cholangiocarcinoma) Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share (2018-2019)
Table Southeast Asia Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share by Type (2014-2019)
Table Southeast Asia Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share by Application (2014-2019)
Figure India Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Bile Duct Cancer (Cholangiocarcinoma) Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share (2018-2019)
Table India Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Type (2014-2019) (Million US$)
Table India Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share by Type (2014-2019)
Table India Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Application (2014-2019) (Million US$)
Table India Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share by Application (2014-2019)
Figure Central & South America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Bile Duct Cancer (Cholangiocarcinoma) Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share (2018-2019)
Table Central & South America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share by Type (2014-2019)
Table Central & South America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Share by Application (2014-2019)
Table Accord Healthcare Company Details
Table Accord Healthcare Revenue in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019) (Million US$)
Figure Accord Healthcare Revenue Growth Rate in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)
Table Accord Healthcare Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Revenue in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Company Revenue Growth Rate in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)
Table Bristol-Myers Squibb Company Recent Development
Table Celgene Corporation Company Details
Table Celgene Corporation Revenue in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)(Million US$)
Figure Celgene Corporation Revenue Growth Rate in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)
Table Celgene Corporation Recent Development
Table Delcath Systems Company Details
Table Delcath Systems Revenue in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)(Million US$)
Figure Delcath Systems Revenue Growth Rate in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)
Table Delcath Systems Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)(Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table F. Hoffman-La Roche Company Details
Table F. Hoffman-La Roche Revenue in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)(Million US$)
Figure F. Hoffman-La Roche Revenue Growth Rate in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)
Table F. Hoffman-La Roche Recent Development
Table Fresenius Kabi Company Details
Table Fresenius Kabi Revenue in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)(Million US$)
Figure Fresenius Kabi Revenue Growth Rate in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)
Table Fresenius Kabi Recent Development
Table Johnson & Johnson Services Company Details
Table Johnson & Johnson Services Revenue in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)(Million US$)
Figure Johnson & Johnson Services Revenue Growth Rate in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)
Table Johnson & Johnson Services Recent Development
Table Kyowa Hakko Kirin Company Details
Table Kyowa Hakko Kirin Revenue in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)(Million US$)
Figure Kyowa Hakko Kirin Revenue Growth Rate in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)
Table Kyowa Hakko Kirin Recent Development
Table Mylan Company Details
Table Mylan Revenue in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)(Million US$)
Figure Mylan Revenue Growth Rate in Bile Duct Cancer (Cholangiocarcinoma) Treatment Business (2014-2019)
Table Mylan Recent Development
Table Novartis Company Details
Table Pfizer Company Details
Table Sanofi Company Details
Table Teva Pharmaceuticals Industries Company Details
Table Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Share by Regions (2019-2025)
Figure Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Share by Regions in 2025
Figure United States Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Product (2019-2025)
Figure Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Product in 2025
Table Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Application (2019-2025)
Figure Global Bile Duct Cancer (Cholangiocarcinoma) Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
転移癌治療の世界市場：市場規模・現状・予測 Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…- 乳がん治療の世界市場：市場規模・現状・予測 Breast cancer is the one of the most prevalent cancer and among the leading cause of death in cancer patients. According, to WHO 2013 report 50800 women died of breast cancer in 2011. Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread …
- 乳がん治療の世界市場：市場規模・現状・予測 Breast cancer is the one of the most prevalent cancer and among the leading cause of death in cancer patients. According, to WHO 2013 report 50800 women died of breast cancer in 2011. Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread …
- 胃腸癌治療の世界市場：市場規模・現状・予測 Gastrointestinal Cancer Devices are various devices used to cure gastrointestinal cancer.Rise in incidences of lymphoma, adenocarcinoma, and gastrointestinal stromal tumors, increase in regulatory approvals for metastatic gastric cancer, low dose radiation technology based devices, and increase in n…
- HER2陰性乳癌治療の世界市場：市場規模・現状・予測 HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu or ErbB2.HER2-negative breast cancer means that the people have little or no HER2 protein.In 2018, the global HER2-negative breast cancer Treatment mar…